Skip to main content
Premium Trial:

Request an Annual Quote

Golden Helix Lands Distributor for Australia, NZ

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bozeman, Mont.-based Golden Helix said today that Millennium Science will distribute its genetic analysis software in Australia and New Zealand.

Under the agreement, Millennium, based in Surrey Hill, Australia, will provide sales and support for the company's SNP and Variation Suite, which is aimed at researchers involved in genome-wide association, copy number analysis, and next-generation sequencing research.

Millennium Managing Director and CEO Bren Collinson said in a statement that the Golden Helix software will "accelerate our customers search for the genetic causes of disease, the development of diagnostics, and pharmacogenetic research."

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.